SEI Investments
RVMD icon

SEI Investments’s Revolution Medicines RVMD Stock Holding History

SEI Investments’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.47M Buy
50,560
+19,774
+64% +$2.89M 0.01% 1156
2026
Q1 		$2.99M Sell
30,786
-31,703
-51% -$3.2M ﹤0.01% 1813
2025
Q4 		$4.98M Buy
62,489
+10,559
+20% +$692K ﹤0.01% 1376
2025
Q3 		$2.43M Buy
51,930
+724
+1% +$28.3K ﹤0.01% 1620
2025
Q2 		$1.88M Sell
51,206
-21,409
-29% -$822K ﹤0.01% 1674
2025
Q1 		$2.57M Sell
72,615
-23,504
-24% -$954K ﹤0.01% 1534
2024
Q4 		$4.2M Sell
96,119
-2,572
-3% -$130K 0.01% 1378
2024
Q3 		$4.48M Buy
98,691
+53,542
+119% +$2.33M 0.01% 1337
2024
Q2 		$1.75M Buy
45,149
+28,778
+176% +$1.08M ﹤0.01% 1691
2024
Q1 		$528K Buy
+16,371
New +$485K ﹤0.01% 2096
2023
Q2 		– Sell
-11,156
Closed -$242K – 2748
2023
Q1 		$242K Buy
+11,156
New +$275K ﹤0.01% 2419

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

SEI Investments's RVMD Position: Q2 2026 in Review

SEI Investments increased its Revolution Medicines (RVMD) stake by 64% in Q2 2026, buying an estimated $2.89M and bringing the position to 50,560 shares worth $9.47M. The position accounts for 0.01% of the portfolio, ranked #1156.

SEI Investments first reported a position in RVMD in Q1 2023 and has held it in 11 quarters since. 693 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • SEI Investments held 50,560 shares of Revolution Medicines worth $9.47M as of Q2 2026.
  • SEI Investments bought 19,774 Revolution Medicines shares in Q2 2026, an estimated $2.89M.
  • Revolution Medicines made up 0.01% of SEI Investments's portfolio in Q2 2026, its #1156 holding.
  • SEI Investments first reported a position in Revolution Medicines in Q1 2023 and has held it in 11 quarters since.
  • 693 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.